中国药品标准2024,Vol.25Issue(5) :495-500.DOI:10.19778/j.chp.2024.05.011

酶解-高效液相色谱法测定玻璃酸钠注射液的含量

Determination of sodium hyaluronate injection by enzymatic hydrolysis-HPLC

张晶 覃婷婷 韩晓捷
中国药品标准2024,Vol.25Issue(5) :495-500.DOI:10.19778/j.chp.2024.05.011

酶解-高效液相色谱法测定玻璃酸钠注射液的含量

Determination of sodium hyaluronate injection by enzymatic hydrolysis-HPLC

张晶 1覃婷婷 1韩晓捷1
扫码查看

作者信息

  • 1. 天津市药品检验研究院,天津 300070
  • 折叠

摘要

目的:建立玻璃酸钠注射液含量的测定方法.方法:采用透明质酸酶对样品进行酶解,优化酶浓度、反应温度、反应时长(100 IU·mg-1,37℃,4 h).色谱柱为 Shodex sugar SH1011(300 mm ×8 mm,6 μm),流动相为1%磷酸,流速:0.6 mL·min-1;检测波长:230 nm.结果:玻璃酸钠在101.38~1 013.76 μg·mL-1浓度范围内线性良好(r=0.999 5);精密度、稳定性、重复性试验的RSD<1%;平均加样回收率为100.4%,RSD=2.0%(n=9);与比色法结果的RAD为0.1%~1.2%.结论:该方法准确度高、重复性好,适用于玻璃酸钠注射液的含量测定.

Abstract

Objective:To establish a determination method for sodium hyaluronate injection.Methods:Sodium hyaluronate was specifically hydrolyzed by hyaluronidase,and the optimal enzymolysis conditions were enzymolysis at 37 ℃ for 4 h at 100 IU·mg-1 of enzyme reaction concentration.The analysis was performed on a of Shodex sug-ar SH1011 column(300 mm ×8 mm,6 μm)with a mobile phase of 1%H3PO4 at a flow rate of 0.6 mL·min-1.The eluent was detected at 230 nm.Results:Linear ranges were 101.38-1 013.76 µg·mL-1(r=0.999 5),RSDs of precision,stability and repeatability tests were lower than 1%,and average recovery was 100.4%,RSD=2.0%(n=9).The RAD of determination results of this method and colorimetric was 0.1%-1.2%.Conclusions:The method is accurate and reproducible,and can be used for the determination of sodium hyalur-onate injection.

关键词

玻璃酸钠/酶解/高效液相色谱/透明质酸酶/比色法/含量测定

Key words

sodium hyaluronate/enzymolysis/HPLC/hyaluronidase/colorimetry/assay

引用本文复制引用

出版年

2024
中国药品标准
国家药典委员会

中国药品标准

影响因子:0.372
ISSN:1009-3656
段落导航相关论文